Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2012 075 202.5 |
96 | EP file number | EAKZ | 12 70 0294.7 |
86 | WO file number | WAKZ | PCT/GB2012/050002 |
97 | EP publication number | EPN | 2661263 |
87 | WO publication number | WPN | 2012093255 |
54 | Designation/title | TI | VERWENDUNG DES PHYTOCANNABINOIDS CANNABIDIOL (CBD) IN KOMBINATION MIT EINEM STANDARD ANTIEPILEPTIKUM (SAED) ZUR BEHANDLUNG VON EPILEPSIE |
51 | IPC main class | ICM (ICMV) | A61K 31/05 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/19 (2006.01), A61K 31/4015 (2006.01), A61P 25/08 (2006.01) |
22 | DE application date | DAT | Jan 3, 2012 |
96 | EP application date | EAT | Jan 3, 2012 |
86 | WO application date | WAT | Jan 3, 2012 |
43 | Date of first publication | OT | Jul 12, 2012 |
| Date of publication of grant | PET | Apr 14, 2021 |
71/73 | Applicant/owner | INH | GW Pharma Ltd., Histon, Cambridge, GB |
72 | Inventor | IN | WHALLEY, Benjamin, Reading RG6 6AP, GB; WILLIAMS, Claire, Reading RG6 6AP, GB; STEPHENS, Gary, Reading RG6 6AP, GB |
74 | Representative | VTR | HGF Europe LLP, 81673 München, DE |
| Address for service | | HGF Europe LLP, 81673 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 201100043 Jan 4, 2011
|
| Due date | FT FG | Jan 31, 2026 Annual fee for the 15th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002661263 Searchable text:
EP000002661263 Original document:
EP000002661263B1 Searchable text:
EP000002661263B1 Original document:
WO002012093255 Searchable text:
WO002012093255 |
43 | Date of first publication | EVT | Jul 12, 2012 |
| Date of the first transfer into DPMAregister | EREGT | Dec 25, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 27, 2024 (Show all update days)(Hide all update days)- Nov 27, 2024
- Sep 19, 2024
- Procedures: Procedure relating to PCT application, Publication of PCT application, 12.07.2012: deleted
- May 9, 2024; Jan 26, 2024; Jun 7, 2023; Apr 29, 2023; Jan 31, 2023; Apr 7, 2022; Mar 3, 2022; Jan 27, 2022; Jun 25, 2021; May 6, 2021; Mar 30, 2021; Mar 25, 2021; Aug 12, 2019; Feb 14, 2019; Oct 12, 2017; Apr 6, 2017
- Historical data not available for this/these date(s)
- Dec 25, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 28, 2023 |
| Issue number | HN | 23 |
| Year | PJ | 2023 |
| Publication date | VT | Jun 7, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | GW Pharma Ltd., Histon, Cambridge, GB |
71/73 | Previous applicant/owner | INHF | GW Pharma Ltd., Histon, Cambridge, GB, Otsuka Pharmaceutical Co., Ltd., Tokyo, JP |
| Date of update of the procedure | REGT | Jun 7, 2023 |